Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi ...

According to the American College of Cardiology, nearly 6.7 million Americans have heart failure, more than half with preserved ejection fraction. This condition often leads to frequent ...

Having an LDL of less than 100 milligrams per deciliter (mg/dL) has been linked to a lower risk of cardiovascular events. And ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...

The Phase 2, randomized, double-blind clinical trial included 23 patients randomized to either 200 mg ataciguat (n=12) or placebo (n=11) once daily for a 12-month period. The primary Phase 2 clinical ...

The startup is advancing a drug licensed from China’s Hengrui Pharma that it claims could be “best-in-class” among a group of ...

Some of the sport’s greatest have labelled the Theatre of Dreams their home and condensing an all-time great Manchester United players list into a top 25 was incredibly tough. Nevertheless, Sports ...

Last Updated on November 7, 2025 by Daily News Staff The Heart-Body Connection: How other organ systems affect heart health ...

Global rates of hypertension, or high blood pressure, in childhood and adolescence have nearly doubled since 2000, putting ...

People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in ...

Nearly two years ago, Chad Gluss went into cardiac arrest and wound up needing a heart transplant. In January, he will be ...